About Phoreus Biotech
Phoreus Biotech is a private company based in Olathe, Kansas. It has reported $5,405,323 raised in three offerings on Form D since August 2018. Its chief executive is David Schaefer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Mar 13, 2026 | $420,693target not set | 3 | $140K | Equity, OptionsRule 506(b) | Form D ↗ |
| Jul 20, 2020 | May 26, 2020amended Mar 13, 2026 | $4,434,630target not set | 49 | $90,503 | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Jul 30, 2018 | Aug 2, 2018amended Dec 30, 2019 | $550,000of $1.1M target | 7 | $78,571 | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, three offerings | $5,405,323 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Phoreus Biotech's Form D filed Mar 13, 2026.
SN
Scott Nagley
Director
Douglas Shane
Board Member
Bill Ashley
Board Member
SS
MT
Matthew Tomich
Board Chairman
RP
Rajeet Pannu
Director and promoter
Earlier filings also listed Xiomara Sinisterra-Hunter (director, last listed Dec 2019), Randall Tosh (chief executive officer and director, last listed Dec 2019), Michael Coe (executive officer and director, last listed Dec 2019) and Christopher Brandt (director, last listed Dec 2019).
Sources
- SECPhoreus Biotechnology, Inc. Form D/A, filed May 11, 2022
- SECPhoreus Biotechnology, Inc. Form D, filed May 26, 2020
- SECPhoreus Biotechnology, Inc. Form D/A, filed Jul 19, 2019
- SECPhoreus Biotechnology, Inc. Form D, filed Aug 2, 2018
- SECPhoreus Biotechnology, Inc. filing history
- CompanyAbout Phoreus Biotech
- CompanyBAPtofect-25 launch